UDP Glucuronosyltransferase 2 Family, Polypeptide A3 (UGT2A3) Peptide
UGT2A3
Reactivity: Mammalian
Host: Synthetic
BP, WB, IHC
-
- Target See all UGT2A3 products
- UGT2A3 (UDP Glucuronosyltransferase 2 Family, Polypeptide A3 (UGT2A3))
- Peptide Type
- Synthetic
- Origin
- Mammalian
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequence
- GIVVFSLGSL FQNVTEEKAN IIASALAQIP QKVLWRYKGK KPSTLGANTR
- Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of µgT2 A3 antibody,
Alternative Names: UGT2A3 control peptide, µgT2A3 antibody Blocking Peptide, Anti-UGT2A3 Blocking Peptide, Udp Glucuronosyltransferase 2 Family Polypeptide A3 Blocking Peptide, FLJ21934 Blocking Peptide, µgT2A3, µgTA3-2, µgTA3 2, µgTA3-2 Blocking Peptide, µgTA3 2 Blocking Peptide
-
-
- Application Notes
- Optimal conditions should be determined by the investigator
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- -20 °C
- Storage Comment
- Store at -20 °C long term.
-
- Target
- UGT2A3 (UDP Glucuronosyltransferase 2 Family, Polypeptide A3 (UGT2A3))
- Synonyms
- UGT2A1 Peptide, zgc:112491 Peptide, 2010321J07Rik Peptide, RGD1308444 Peptide, Ugt2a3 Peptide, UDP glucuronosyltransferase 2 family, polypeptide A1, complex locus Peptide, UDP glucuronosyltransferase family 2 member A3 Peptide, UDP glucuronosyltransferase family 2 member A1 complex locus Peptide, UDP glucuronosyltransferase 2 family, polypeptide A3 Peptide, UDP-glucuronosyltransferase 2A3 Peptide, UDP-glucuronosyltransferase 2A3-like Peptide, UGT2A1 Peptide, UGT2A3 Peptide, LOC100351592 Peptide, LOC100359229 Peptide, ugt2a3 Peptide, LOC100596311 Peptide, Ugt2a3 Peptide, LOC100135631 Peptide
- Background
- UGT2A3 belongs to the UDP-glycosyltransferase family. UDP-glucuronosyltransferases catalyze phase II biotransformation reactions in which lipophilic substrates are conjugated with glucuronic acid to increase water solubility and enhance excretion. They are of major importance in the conjugation and subsequent elimination of potentially toxic xenobiotics and endogenous compounds.
- Molecular Weight
- 60 kDa
-
You are here:
